CompletedNot Applicable

Impact of Renal Replacement Therapy on Coagulation Profile of Patients with Acute Renal Failure

France14 participantsStarted 2018-08-18

Plain-language summary

Renal failure and high plasmatic level of urea have been associated with an increased risk of hemorrhage in surgical patients. There is only sparse data on the impact of renal replacement therapy on homeostatic parameters. The aim of this study is to describe potential changes in homeostatic parameters before and after renal replacement therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * critically ill patients * acute renal failure * renal replacement therapy * plasmatic urea \> 20 Exclusion Criteria: * chronic renal failure * platelet count less than 80 Giga * V factor less than 70%

What they're measuring

visco elastometry

Timeframe: Change in ROTEM parameters from baseline to after renal replacement therapy

Trial details

NCT IDNCT03536195

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-11-23

View on ClinicalTrials.gov More Acute Renal Failure trials